ORAL PROLONGED-ACTION MEDICATION

被引:9
作者
CAMPBELL, JA
MORRISON, AB
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1962年 / 181卷 / 02期
关键词
D O I
10.1001/jama.1962.03050280032005b
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:102 / &
相关论文
共 21 条
[1]   THE POWERFUL PLACEBO [J].
BEECHER, HK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 159 (17) :1602-1606
[2]  
BLYTHE RH, 1958, DRUG STAND, V26, P1
[3]  
CAMPBELL J A, 1957, Can Med Assoc J, V77, P602
[4]  
CHAPMAN D G, 1959, Can Med Assoc J, V81, P470
[5]   THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF SODIUM PARA-AMINOSALICYLATE [J].
CHAPMAN, DG ;
CRISAFIO, R ;
CAMPBELL, JA .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1956, 45 (06) :374-378
[6]   THE RELATION BETWEEN INVITRO DISINTEGRATION TIME OF SUGAR-COATED TABLETS AND PHYSIOLOGICAL AVAILABILITY OF RIBOFLAVIN [J].
CHAPMAN, DG ;
CRISAFIO, R ;
CAMPBELL, JA .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION-SCIENTIFIC EDITION, 1954, 43 (05) :297-304
[7]   ORAL MEDICATION WITH PREPARATIONS FOR PROLONGED ACTION [J].
DRAGSTEDT, CA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 168 (12) :1652-1655
[8]   ORAL PROLONGED ACTION MEDICAMENTS - THEIR PHARMACEUTICAL CONTROL AND THERAPEUTIC ASPECTS [J].
LAZARUS, J ;
COOPER, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1959, 11 (05) :257-290
[10]   PHARMACEUTICAL FORMULATION AND THERAPEUTIC EFFICACY [J].
LEVY, G ;
NELSON, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 177 (10) :689-&